Building Stakeholder Engagement Through EAPs

BUILDING STAKEHOLDER ENGAGEMENT THROUGH EAPs Download our guide on leveraging Early Access Programs to engage healthcare professionals, payers, and empower eligible patients with early access to innovative therapies. Gain valuable insights, contribute to real-world [...]

By |2024-03-26T15:08:55+00:00March 4th, 2024|

International Recognition Procedure

International Recognition Procedure From January 2024, the MHRA is adopting the International Recognition Procedure, reflecting a strategic pivot towards an independent and collaborative regulatory framework for swift and secure drug authorizations in the UK. Our [...]

By |2024-03-07T13:34:51+00:00December 19th, 2023|

EU Health Technology Assessments

Navigating the Future of EU Joint Health Technology Assessments With the Health Technology Assessment (HTA) landscape undergoing transformation in January 2025, it's essential to prepare your pipeline for what lies ahead. Our Market Access [...]

By |2024-03-26T15:18:21+00:00November 2nd, 2023|
Go to Top